Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury

• Published in: PloS one 2019-09, Vol.14 (9), p.e0222033
• Main Authors: Zhang, Jingwei, Zhao, Zhenzhen, Bai, Hao, Wang, Minjin, Jiao, Lin, Peng, Wu, Wu, Tao, Liu, Tangyuheng, Chen, Hao, Song, Xingbo, Wu, Lijuan, Hu, Xuejiao, Wu, Qian, Zhou, Juan, Song, Jiajia, Lyv, Mengyuan, Ying, Binwu
• Format: Article
• Language: English
• Subjects: Adult; Alleles; Antitubercular Agents - adverse effects; Biochemistry; Biology and Life Sciences; Case-Control Studies; Chemical and Drug Induced Liver Injury - genetics; Confidence intervals; Cytochrome; Desertification; Enzymes; Epidemiology; Female; Gastroenterology; Gene frequency; Genes; Genetic Predisposition to Disease - genetics; Genetics; Genotypes; Haplotypes; Hepatology; Homeostasis; Hospitals; Humans; Inflammation; Injuries; Laboratories; Ligands; Liver; Liver X receptors; Male; Medical research; Medicine; Medicine and Health Sciences; Metabolism; NF-kappa B p50 Subunit - genetics; NF-κB protein; Nucleotides; Pathogenesis; Patients; Polymorphism, Single Nucleotide; Pregnane X Receptor - genetics; Prospective Studies; Research and Analysis Methods; Side effects; Single-nucleotide polymorphism; Transcription; Transcription factors; Tuberculosis; Tumor necrosis factor-TNF
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0222033

Pregnane X receptor (PXR) regulates the expression of drug-metabolizing enzymes and transport enzymes. NF-κB not only plays a role in liver homeostasis and injury-healing processes by regulating inflammatory responses but may also regulate the transcription of PXR. Currently, genetic polymorphisms in PXR are associated with adverse drug effects. Because little is known about the association between NF-κB1 genetic polymorphisms and adverse drug reactions, we explored the association between PXR and NF-κB1 single nucleotide polymorphisms (SNPs) and susceptibility to anti-tuberculosis drug-induced liver injury (ATDILI). A total of 746 tuberculosis patients (118 with ATDILI and 628 without ATDILI) were prospectively enrolled at West China Hospital between December 2014 and April 2018. Nine selected SNPs (rs3814055, rs13059232, rs7643645 and rs3732360 in PXR and rs78872571, rs4647992, rs60371688, rs1598861 and rs3774959 in NF-κB1) were genotyped with a custom-designed 2x48-plex SNP Scan TM Kit. The frequencies of the alleles, genotypes and genetic models of the variants were compared between patients with or without ATDILI, while joint effect analysis of the SNP-SNP interactions was performed using multiplicative and additive models. The odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were calculated. The T allele of rs3814055 in PXR was associated with a decreased risk for ATDILI (OR 0.61; 95% CI: 0.42-0.89, p = 0.0098). The T alleles of rs78872571 and rs4647992 in NF-κB1 were significantly associated with an increased risk for ATDILI (OR 1.91; 95% CI: 1.06-3.43, p = 0.028 and OR 1.81; 1.06-3.10, p = 0.029, respectively). The allele, genotype and genetic model frequencies were similar in the two groups for the other six SNPs (all P>0.05). There were no multiplicative or additive interactions between the SNPs. Our study is the first to reveal that rs3814055 variants in PXR and rs78872571 and rs4647992 variants in NF-κB1 are associated with susceptibility to ATDILI caused by first-line anti-tuberculosis combination treatment in the Han Chinese population.